Brief: Profound Medical Q3 EPS USD -0.26
13/11/2025 21:05
Nov 13 (Reuters) - Profound Medical Q3 revenue USD 5.3 million vs. IBES estimate USD 4.72 million. Q3 net income USD -8 million Q3 operating expenses USD 12.8 million
- CA$300.17m
- CA$252.95m
- $16.10m